These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 21849297)
1. Anti-Mullerian hormone--is it a crystal ball for predicting ovarian ageing? Loh JS; Maheshwari A Hum Reprod; 2011 Nov; 26(11):2925-32. PubMed ID: 21849297 [TBL] [Abstract][Full Text] [Related]
2. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131 [TBL] [Abstract][Full Text] [Related]
4. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015 [TBL] [Abstract][Full Text] [Related]
5. The role of anti-Müllerian hormone in female fertility and infertility - an overview. Grynnerup AG; Lindhard A; Sørensen S Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1252-60. PubMed ID: 22646322 [TBL] [Abstract][Full Text] [Related]
6. [Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions]. Yu M; Deng CY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):114-9. PubMed ID: 19317075 [TBL] [Abstract][Full Text] [Related]
7. Is the measurement of anti-Müllerian hormone essential? Usta T; Oral E Curr Opin Obstet Gynecol; 2012 Jun; 24(3):151-7. PubMed ID: 22487725 [TBL] [Abstract][Full Text] [Related]
8. [Measurement of serum AMH levels in gynecology: indications and limits]. Streuli I; Cantero-Perez P; Miserez-Zaugg C Rev Med Suisse; 2013 Oct; 9(403):1954-6, 1958. PubMed ID: 24245018 [TBL] [Abstract][Full Text] [Related]
9. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843 [TBL] [Abstract][Full Text] [Related]
10. Genetic variation may modify ovarian reserve in female childhood cancer survivors. van Dorp W; van den Heuvel-Eibrink MM; Stolk L; Pieters R; Uitterlinden AG; Visser JA; Laven JS Hum Reprod; 2013 Apr; 28(4):1069-76. PubMed ID: 23360674 [TBL] [Abstract][Full Text] [Related]
11. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor. Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118 [TBL] [Abstract][Full Text] [Related]
12. Anti-Mullerian hormone (AMH): what do we still need to know? La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS; Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713 [TBL] [Abstract][Full Text] [Related]
13. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Singer T; Barad DH; Weghofer A; Gleicher N Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223 [TBL] [Abstract][Full Text] [Related]
14. [Level of AMH as a predictor of the result of ovarian stimulation]. Vrublovský P Ceska Gynekol; 2016 Jan; 81(1):23-6. PubMed ID: 26982060 [TBL] [Abstract][Full Text] [Related]
15. Recent progress in the utility of anti-Müllerian hormone in female infertility. Grynnerup AG; Lindhard A; Sørensen S Curr Opin Obstet Gynecol; 2014 Jun; 26(3):162-7. PubMed ID: 24722366 [TBL] [Abstract][Full Text] [Related]
16. Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Yates AP; Rustamov O; Roberts SA; Lim HY; Pemberton PW; Smith A; Nardo LG Hum Reprod; 2011 Sep; 26(9):2353-62. PubMed ID: 21672928 [TBL] [Abstract][Full Text] [Related]
17. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients? Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870 [TBL] [Abstract][Full Text] [Related]
18. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
19. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941 [TBL] [Abstract][Full Text] [Related]
20. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles. Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]